Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
PharmX Technologies ( (AU:PHX) ) has issued an announcement.
PharmX Technologies has issued 59,950,679 new fully paid ordinary shares at $0.145 each to CW Retail Holdings, a subsidiary of Sigma Healthcare, as part of a binding multi-year strategic alliance. The company confirmed the shares were issued without a prospectus in reliance on Australian Corporations Act provisions and stated it is compliant with continuous disclosure and reporting obligations, indicating regulatory transparency as it deepens ties with a major healthcare partner.
The share issuance strengthens PharmX’s capital base and formalises a long-term strategic relationship with Sigma Healthcare’s retail arm, potentially enhancing its reach across pharmacy networks and supporting future growth initiatives. By aligning with a significant industry player while maintaining compliance and signalling no undisclosed price-sensitive information, PharmX reinforces its market positioning in the ANZ pharmatech infrastructure segment and provides clarity to investors on the nature of the expansion.
More about PharmX Technologies
PharmX Technologies is a leading pharmacy ordering platform in Australia and New Zealand, providing core infrastructure for seamless ordering and inventory management across a large network of pharmacies, suppliers, and technology vendors. Its high-availability platform processes about $20 billion in transactions annually and underpins ordering, eInvoicing, and analytics solutions in a growing, regulation-driven pharmatech market.
Average Trading Volume: 801,475
Technical Sentiment Signal: Buy
Current Market Cap: A$86.93M
For an in-depth examination of PHX stock, go to TipRanks’ Overview page.